RAIDD/CRADD Antibody, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NBP177048-Each-of-1 | In Stock | ₹ 43,387.50 |
NBP177048 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 43,387.50
GST (18%): ₹ 7,809.75
Total Price: ₹ 51,197.25
Antigen
RAIDD/CRADD
Classification
Polyclonal
Conjugate
Unconjugated
Formulation
PBS with 0.02% Sodium Azide
Gene Alias
CASP2 and RIPK1 domain containing adaptor with death domain, Caspase and RIP adapter with death domain, caspase and RIP adaptor with death domain, death domain containing protein CRADD, death domain-containing protein CRADD, MGC9163, RAIDDdeath adaptor molecule RAIDD, RIP-associated ICH1/CED3-homologous protein with death domain, RIP-associated protein with a death domain
Host Species
Rabbit
Molecular Weight of Antigen
18 kDa
Quantity
0.1 mg
Research Discipline
Apoptosis, Cancer, Cell Biology, Tumor Suppressors
Gene ID (Entrez)
8738
Content And Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Applications
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin)
Concentration
1 mg/ml
Dilution
Western Blot 2 μg/mL, ELISA 1:100-1:2000, Immunohistochemistry 10 μg/mL, Immunocytochemistry/Immunofluorescence 5 μg/mL, Immunohistochemistry-Paraffin 10 μg/mL
Gene Accession No.
AAB42217
Gene Symbols
CRADD
Immunogen
Antibody was raised against a peptide corresponding to amino acids near the carboxy terminus of human RAIDD. The immunogen is located within the last 50 amino acids of RAIDD. Amino Acid Squence: HNGLRAVEVDPSLLLHMLE
Purification Method
Ion exchange chromatography
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Isotype
IgG
Related Products
Description
- RAIDD/CRADD Polyclonal specifically detects RAIDD/CRADD in Human samples
- It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.